Alerts will be sent to your verified email
Verify Email
CHCL
|
Cian Healthcare
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-2.49 % | 1.59 % | 13.7 % |
|
5yr average Equity Multiplier
|
2.79 | 1.99 | 1.24 |
|
5yr Average Asset Turnover Ratio
|
0.42 | 1.33 | 0.36 |
|
5yr Avg Net Profit Margin
|
-2.06 % | -0.06 % | 71.53 % |
|
Price to Book
|
0.0 | 1.26 | 2.08 |
|
P/E
|
58.78 | 0.0 | 39.89 |
|
5yr Avg Cash Conversion Cycle
|
-692.15 Days | 82.44 Days | 68.18 Days |
|
Inventory Days
|
163.23 Days | 64.96 Days | 62.21 Days |
|
Days Receivable
|
131.14 Days | 72.97 Days | 10.88 Days |
|
Days Payable
|
473.59 Days | 84.21 Days | 199.95 Days |
|
5yr Average Interest Coverage Ratio
|
0.8 | 2.35 | 815.2 |
|
5yr Avg ROCE
|
5.59 % | 5.35 % | 19.97 % |
|
5yr Avg Operating Profit Margin
|
14.07 % | 3.76 % | -101.39 % |
|
5 yr average Debt to Equity
|
1.12 | 0.49 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | 0.0 |
|
5yr Average Return on Assets
|
-0.86 % | 0.6 % | 10.86 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.1 % | 51.49 % | 59.53 % |
|
Share Pledged by Promoters
|
34.48 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-43.79 % | 0.0 | 3.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Cian Healthcare
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|